These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 27328806)
1. Rapid Benefits of Structured Optimization and Sensor-Augmented Insulin Pump Therapy in Adults With Type 1 Diabetes. Leelarathna L; Thabit H; Hartnell S; Willinska ME; Dellweg S; Benesch C; Mader JK; Holzer M; Kojzar H; Evans ML; Arnolds S; Pieber TR; Hovorka R; J Diabetes Sci Technol; 2017 Jan; 11(1):180-181. PubMed ID: 27328806 [No Abstract] [Full Text] [Related]
2. A Mobile Application Guiding Patients With Type 1 Diabetes Using Sensor-Augmented Insulin Pump Therapy. Esvant A; Lefebvre MA; Campillo-Gimenez B; Lannes M; Delamarre D; Guilhem I; Poirier JY J Diabetes Sci Technol; 2016 Jul; 10(4):985-6. PubMed ID: 26902791 [No Abstract] [Full Text] [Related]
3. Health-economic analysis of real-time continuous glucose monitoring in people with Type 1 diabetes. Roze S; Saunders R; Brandt AS; de Portu S; Papo NL; Jendle J Diabet Med; 2015 May; 32(5):618-26. PubMed ID: 25483869 [TBL] [Abstract][Full Text] [Related]
4. Effect of sensor-augmented insulin pump therapy and automated insulin suspension vs standard insulin pump therapy on hypoglycemia in patients with type 1 diabetes: a randomized clinical trial. Ly TT; Nicholas JA; Retterath A; Lim EM; Davis EA; Jones TW JAMA; 2013 Sep; 310(12):1240-7. PubMed ID: 24065010 [TBL] [Abstract][Full Text] [Related]
5. Severe Hypoglycemia Before Landing in a Patient with Type 1 Diabetes Using Sensor-Augmented Pump Therapy. Viñals C; Pané A; Quirós C; Giménez M; Conget I Diabetes Technol Ther; 2017 Aug; 19(8):491-492. PubMed ID: 28594566 [No Abstract] [Full Text] [Related]
6. Insulin-pump therapy for type 1 diabetes mellitus. Pickup JC N Engl J Med; 2012 Apr; 366(17):1616-24. PubMed ID: 22533577 [No Abstract] [Full Text] [Related]
7. Management of insulin pump therapy in children with type 1 diabetes. Abdullah N; Pesterfield C; Elleri D; Dunger DB Arch Dis Child Educ Pract Ed; 2014 Dec; 99(6):214-20. PubMed ID: 25125555 [TBL] [Abstract][Full Text] [Related]
8. Use of sensor-augmented insulin pump in patient with diabetes and cystic fibrosis: evidence for improvement in metabolic control. Klupa T; Małecki M; Katra B; Cyganek K; Skupień J; Kostyk E; Pietrzyk J; Sieradzki J Diabetes Technol Ther; 2008 Feb; 10(1):46-9. PubMed ID: 18275362 [TBL] [Abstract][Full Text] [Related]
9. Sensor Augmented Pump Therapy Use in Type 1 Diabetes Mellitus. Carolan E; Murphy NP Ir Med J; 2016 Dec; 109(10):477. PubMed ID: 28644582 [No Abstract] [Full Text] [Related]
10. "Let the Algorithm Do the Work": Reduction of Hypoglycemia Using Sensor-Augmented Pump Therapy with Predictive Insulin Suspension (SmartGuard) in Pediatric Type 1 Diabetes Patients. Biester T; Kordonouri O; Holder M; Remus K; Kieninger-Baum D; Wadien T; Danne T Diabetes Technol Ther; 2017 Mar; 19(3):173-182. PubMed ID: 28099035 [TBL] [Abstract][Full Text] [Related]
11. Long-Term Efficacy and Safety of Sensor Augmented Insulin Pump Therapy with Low-Glucose Suspend Feature in Patients with Type 1 Diabetes. Gómez AM; Marín Carrillo LF; Muñoz Velandia OM; Rondón Sepúlveda MA; Arévalo Correa CM; Mora Garzón E; Cuervo Diaz MC; Henao Carrillo DC Diabetes Technol Ther; 2017 Feb; 19(2):109-114. PubMed ID: 28001445 [TBL] [Abstract][Full Text] [Related]
12. [Insulin pump regulated by a glucose sensor; one step closer to closing the loop for type 1 diabetes patients]. de Valk HW Ned Tijdschr Geneeskd; 2019 Sep; 163():. PubMed ID: 31556504 [TBL] [Abstract][Full Text] [Related]
13. A cost-effectiveness analysis of sensor-augmented insulin pump therapy and automated insulin suspension versus standard pump therapy for hypoglycemic unaware patients with type 1 diabetes. Ly TT; Brnabic AJ; Eggleston A; Kolivos A; McBride ME; Schrover R; Jones TW Value Health; 2014 Jul; 17(5):561-9. PubMed ID: 25128049 [TBL] [Abstract][Full Text] [Related]
15. Overnight Counter-Regulatory Hormone Levels and Next Day Glycemia in Adults with Type 1 Diabetes During Closed-Loop Insulin Delivery Versus Sensor-Augmented Pump with Low-Glucose Suspend. Graf A; Ward GM; Vogrin S; Sundararajan V; Sharifi A; De Bock MI; Jayawardene D; Loh MM; Horsburgh JC; Berthold CL; Paramalingam N; Bach LA; Colman PG; Davis EA; Grosman B; Jenkins AJ; Kumareswaran K; Kurtz N; Kyoong A; MacIsaac RJ; Roy A; Jones TW; O'Neal DN Diabetes Technol Ther; 2017 Jul; 19(7):438-439. PubMed ID: 28537427 [No Abstract] [Full Text] [Related]
16. Long-term health economic benefits of sensor-augmented pump therapy vs continuous subcutaneous insulin infusion alone in type 1 diabetes: a U.K. perspective. Roze S; Smith-Palmer J; Valentine WJ; Cook M; Jethwa M; de Portu S; Pickup JC J Med Econ; 2016; 19(3):236-42. PubMed ID: 26510389 [TBL] [Abstract][Full Text] [Related]
17. Putting brakes on insulin pump infusion to prevent hypoglycemia. Cengiz E J Diabetes Sci Technol; 2011 Sep; 5(5):1142-3. PubMed ID: 22027307 [TBL] [Abstract][Full Text] [Related]
18. Optimal glycaemic control during caesarean section provided by sensor-augmented pump therapy with predictive low-glucose suspend function. Beato-Víbora PI; Arroyo-Díez FJ Acta Diabetol; 2018 Oct; 55(10):1083-1085. PubMed ID: 29987593 [No Abstract] [Full Text] [Related]
19. Home use of a bihormonal bionic pancreas versus insulin pump therapy in adults with type 1 diabetes: a multicentre randomised crossover trial. El-Khatib FH; Balliro C; Hillard MA; Magyar KL; Ekhlaspour L; Sinha M; Mondesir D; Esmaeili A; Hartigan C; Thompson MJ; Malkani S; Lock JP; Harlan DM; Clinton P; Frank E; Wilson DM; DeSalvo D; Norlander L; Ly T; Buckingham BA; Diner J; Dezube M; Young LA; Goley A; Kirkman MS; Buse JB; Zheng H; Selagamsetty RR; Damiano ER; Russell SJ Lancet; 2017 Jan; 389(10067):369-380. PubMed ID: 28007348 [TBL] [Abstract][Full Text] [Related]
20. Comparison of dual-hormone artificial pancreas, single-hormone artificial pancreas, and conventional insulin pump therapy for glycaemic control in patients with type 1 diabetes: an open-label randomised controlled crossover trial. Haidar A; Legault L; Messier V; Mitre TM; Leroux C; Rabasa-Lhoret R Lancet Diabetes Endocrinol; 2015 Jan; 3(1):17-26. PubMed ID: 25434967 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]